Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Steven J. M. Jones | Richard A. Moore | Lisle E. Mose | Zachary J. Heins | David I Heiman | Sheila M. Reynolds | D. Haussler | S. Gabriel | C. Sander | H. Aburatani | R. Gibbs | L. Chin | G. Getz | M. Meyerson | C. Perou | J. Weinstein | G. Mills | K. Ahn | D. Muzny | L. Lewis | H. Dinh | J. Santibanez | L. Donehower | D. Wheeler | R. Verhaak | M. Lawrence | R. Beroukhim | Nicolas Stransky | P. Laird | D. Weisenberger | D. V. Berg | S. Baylin | N. Schultz | M. Ladanyi | D. Hayes | K. Hoadley | S. Balu | Yan Shi | R. Penny | T. Shelton | S. Morris | M. Ferguson | S. Kakar | H. Noushmehr | J. Schein | M. Wilkerson | Kiley Graim | O. Lichtarge | M. Marra | N. Thiessen | T. Giordano | D. Jain | I. Shmulevich | Wei Zhang | R. Holt | A. G. Robertson | Angela Tam | P. Mieczkowski | Hui Shen | J. Parker | Jaegil Kim | G. Saksena | Douglas Voet | M. Noble | Pei Lin | David I. Heiman | Jianjiong Gao | Josh Stuart | Z. Ju | J. Kocher | Juok Cho | A. Mungall | K. Mungall | Y. Totoki | Hiromi Nakamura | T. Shibata | Adrian Ally | M. Balasundaram | Eric Chuah | Noreen Dhalla | Darlene Lee | Michael Mayo | R. Akbani | J. Bowen | J. Gastier-Foster | T. Lichtenberg | L. Wise | John A. Demchok | Margi Sheth | H. Sofia | Liming Yang | S. Schumacher | W. Rathmell | C. Creighton | Donna Morton | H. Doddapaneni | W. Hale | A. Cherniack | Payal Sipahimalani | R. Carlsen | J. Auman | Donghui Tan | Corbin D. Jones | S. Jefferys | T. Bodenheimer | A. Hoyle | J. Simons | Phillip H. Lai | M. Bootwalla | Hailei Zhang | N. Gehlenborg | S. Frazer | C. Benz | C. Yau | Yiling Lu | R. Shen | C. Shelton | J. Gardner | D. Mallery | J. Paulauskis | Erin E. Curley | L. Thorne | L. Boice | T. Pihl | Zhining Wang | R. Tarnuzzer | J. Zhang | Shogo Yamamoto | Ju-Seog Lee | Yi Han | Sandy Lee | H. El‐Serag | T. Hinoue | S. Meng | Min Wang | T. Skelly | Linghua Wang | Yuexin Liu | R. Bowlby | C. Pedamallu | A. I. Ojesina | Ina Felau | C. Hutter | J. Zenklusen | Sudha Chudamani | Jia Liu | Laxmi Lolla | R. Naresh | Yunhu Wan | Ye Wu | T. DeFreitas | S. Meier | A. Hegde | Shiyun Ling | Ritika Kundra | Angelica Ochoa | F. Sánchez-Vega | Hongxin Zhang | Denise Brooks | K. Kasaian | Yussanne Ma | S. Sadeghi | Tina Wong | C. Cibulskis | Steven E Schumacher | J. Shih | Amy H. Perou | J. Roach | Matthew G. Soloway | Umadevi Veluvolu | Michelle Bellair | K. Covington | R. Glenn | Jianhong Hu | V. Korchina | Wei Li | Xiuping Liu | E. Shinbrot | Liu Xi | D. Crain | M. Gerken | Kristen Leraas | N. Ramirez | E. Zmuda | C. Hagedorn | K. Kang | V. Chandan | N. Giama | C. Moser | D. O'Brien | L. Roberts | M. Torbenson | L. Iype | Meijuan Huang | D. Moore | R. Kelley | T. Welling | D. Kleiner | F. Lang | Siyuan Zheng | Arshi Arora | A. Clarke | Dorothy Cheung | Carmen Helsel | Bradley A. Murray | H. Makhlouf | M. Yeh | R. Dhanasekaran | S. Yim | L. Mishra | Jianping Zhang | X. Su | J. Chen | B. Sohn | J. Shim | P. Tong | K. Tatsuno | Zheng Xia | E. Seiser | F. Innocenti | Amie Radenbaugh | K. Bissig | B. Slagle | Panagiotis Katsonis | Amanda M. Koire | Teng-Kuei Hsu | Charlie Sun | F. Saggioro | D. Tirapelli | C. G. C. Júnior | Ê. D. Mente | O. C. Silva | F. Trevisan | M. Vinco | Joong-Won Park | O. Bathe | Andrea E Holbrook | Mario Berrios | Carrie L. Cibulskis | R. Moore | E. Chuah | K. Leraas | Michelle Vinco | Shogo Yamamoto | Josh M Stuart | Jay Bowen | Yi Han | Walker Hale | N. Stransky | D. Muzny | Steven J. M. Jones

[1]  Keith A. Boroevich,et al.  Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer , 2016, Nature Genetics.

[2]  L. Roberts,et al.  Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances , 2016, F1000Research.

[3]  J. Prieto,et al.  Immunological landscape and immunotherapy of hepatocellular carcinoma , 2015, Nature Reviews Gastroenterology &Hepatology.

[4]  S. Gabriel,et al.  Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution , 2015, Nature Communications.

[5]  Nicholas D. Adams,et al.  New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. , 2015, Nature chemical biology.

[6]  Manal M. Hassan,et al.  Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma , 2015, Clinical Cancer Research.

[7]  J. Zucman‐Rossi,et al.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. , 2015, Gastroenterology.

[8]  M. Meyerson,et al.  Structure and mechanism of activity-based inhibition of the EGF-Receptor by Mig6 , 2015, Nature Structural &Molecular Biology.

[9]  Michael A. Choti,et al.  Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets , 2015, Nature Communications.

[10]  Trevor J Pugh,et al.  Oncotator: Cancer Variant Annotation Tool , 2015, Human mutation.

[11]  Jessica Zucman-Rossi,et al.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets , 2015, Nature Genetics.

[12]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[13]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[14]  Pierre-Olivier Angrand,et al.  Diverse involvement of EZH2 in cancer epigenetics. , 2015, American journal of translational research.

[15]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[16]  S. Fesik,et al.  Small molecule Mcl-1 inhibitors for the treatment of cancer. , 2015, Pharmacology & therapeutics.

[17]  Hiromi Nakamura,et al.  Trans-ancestry mutational landscape of hepatocellular carcinoma genomes , 2014, Nature Genetics.

[18]  W. Sung,et al.  Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification , 2014, Hepatology.

[19]  F. Bunz,et al.  A PTCH1 Homolog Transcriptionally Activated by p53 Suppresses Hedgehog Signaling* , 2014, The Journal of Biological Chemistry.

[20]  O. Lichtarge,et al.  A formal perturbation equation between genotype and phenotype determines the Evolutionary Action of protein-coding variations on fitness , 2014, Genome research.

[21]  Nicolas Stransky,et al.  The landscape of kinase fusions in cancer , 2014, Nature Communications.

[22]  Justin Chu,et al.  BioBloom tools: fast, accurate and memory-efficient host species sequence screening using bloom filters , 2014, Bioinform..

[23]  John N. Weinstein,et al.  PRADA: pipeline for RNA sequencing data analysis , 2014, Bioinform..

[24]  Ge Li,et al.  Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis , 2014, Journal of cellular and molecular medicine.

[25]  T. Soussi.  The TP53 Gene Network in a Postgenomic Era , 2014, Human mutation.

[26]  Z. Derdák,et al.  Obesity-associated mechanisms of hepatocarcinogenesis. , 2014, Metabolism: clinical and experimental.

[27]  R. Gibbs,et al.  Effects of TP53 mutational status on gene expression patterns across 10 human cancer types , 2014, The Journal of pathology.

[28]  W. Sung,et al.  Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma. , 2014, Genomics.

[29]  J. Llovet,et al.  Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design , 2014, Clinical Cancer Research.

[30]  Joshua M. Stuart,et al.  RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection , 2014, PloS one.

[31]  Bruce R Korf,et al.  Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas , 2013, Nature Genetics.

[32]  Angela M. Liu,et al.  miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma , 2014, PloS one.

[33]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[34]  A. Jochemsen.  Reactivation of p53 as therapeutic intervention for malignant melanoma , 2014, Current opinion in oncology.

[35]  Miran Kim,et al.  Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. , 2013, Journal of hepatology.

[36]  Xin Zheng,et al.  Role of the Hedgehog pathway in hepatocellular carcinoma (review). , 2013, Oncology reports.

[37]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[38]  Raul Rabadan,et al.  The integrated landscape of driver genomic alterations in glioblastoma , 2013, Nature Genetics.

[39]  M. Ruden,et al.  Novel anticancer therapeutics targeting telomerase. , 2013, Cancer treatment reviews.

[40]  D. Schadendorf,et al.  TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.

[41]  C. Sander,et al.  Pattern discovery and cancer gene identification in integrated cancer genomic data , 2013, Proceedings of the National Academy of Sciences.

[42]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[43]  M. Taniwaki,et al.  Alterations of the SWI/SNF chromatin remodelling subunit‐BRG1 and BRM in hepatocellular carcinoma , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[44]  David Haussler,et al.  The UCSC genome browser and associated tools , 2012, Briefings Bioinform..

[45]  Vincent Y. F. Tan,et al.  Automatic Relevance Determination in Nonnegative Matrix Factorization with the /spl beta/-Divergence , 2011, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[46]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[47]  Jingde Zhu,et al.  Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas. , 2012, Carcinogenesis.

[48]  J. Valcárcel,et al.  The spliceosome as a target of novel antitumour drugs , 2012, Nature Reviews Drug Discovery.

[49]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[50]  S. Imbeaud,et al.  Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma , 2012, Nature Genetics.

[51]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[52]  X. Wang,et al.  Sixty‐five gene‐based risk score classifier predicts overall survival in hepatocellular carcinoma , 2012, Hepatology.

[53]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[54]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[55]  S. Berger,et al.  IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.

[56]  Jeffrey W. Clark,et al.  Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. , 2012, The oncologist.

[57]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[58]  Kristian Cibulskis,et al.  ContEst: estimating cross-contamination of human samples in next-generation sequencing data , 2011, Bioinform..

[59]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[60]  K. Coombes,et al.  Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer , 2011, Clinical Proteomics.

[61]  G. Getz,et al.  PathSeq: software to identify or discover microbes by deep sequencing of human tissue , 2011, Nature Biotechnology.

[62]  Süleyman Cenk Sahinalp,et al.  deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..

[63]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[64]  K. Robertson,et al.  DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. , 2011, American Journal of Pathology.

[65]  C. Févotte,et al.  Automatic Relevance Determination in Nonnegative Matrix Factorization with the-Divergence , 2011 .

[66]  Stephanie Roessler,et al.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. , 2010, Cancer research.

[67]  Steven J. M. Jones,et al.  De novo assembly and analysis of RNA-seq data , 2010, Nature Methods.

[68]  K. Coombes,et al.  A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers , 2010, Clinical Proteomics.

[69]  Derek Y. Chiang,et al.  MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery , 2010, Nucleic acids research.

[70]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[71]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[72]  H. Tai,et al.  Restoration of leukotriene B(4)-12-hydroxydehydrogenase/15- oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo. , 2010, Lung cancer.

[73]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[74]  Jung-Hwan Yoon,et al.  Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. , 2010, Cancer research.

[75]  S. Thorgeirsson,et al.  Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.

[76]  Derek Y. Chiang,et al.  Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. , 2009, Cancer research.

[77]  Steven J. M. Jones,et al.  Abyss: a Parallel Assembler for Short Read Sequence Data Material Supplemental Open Access , 2022 .

[78]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[79]  Adam B. Olshen,et al.  Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis , 2009, Bioinform..

[80]  Yu Wei,et al.  Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. , 2008, Cancer cell.

[81]  Joshua M. Korn,et al.  Integrated detection and population-genetic analysis of SNPs and copy number variation , 2008, Nature Genetics.

[82]  Joshua M. Korn,et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.

[83]  E. Gelmann,et al.  Silencing Mediator for Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Attenuate Transcriptional Activation by the β-Catenin-TCF4 Complex* , 2008, Journal of Biological Chemistry.

[84]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[85]  Takehide Asano,et al.  Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed‐lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma , 2008, Human mutation.

[86]  Jung-Hwan Yoon,et al.  Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.

[87]  Xuming He,et al.  Non-parametric quantification of protein lysate arrays , 2007, Bioinform..

[88]  P. Laird,et al.  Epigenetic stem cell signature in cancer , 2007, Nature Genetics.

[89]  G. Mills,et al.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.

[90]  S. Thorgeirsson,et al.  A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells , 2006, Nature Medicine.

[91]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[92]  S. Thorgeirsson,et al.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling , 2004, Hepatology.

[93]  Richard M. Simon,et al.  A Paradigm for Class Prediction Using Gene Expression Profiles , 2003, J. Comput. Biol..

[94]  A. Rashid,et al.  Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations , 1999, British Journal of Cancer.

[95]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[96]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[97]  S. Grundy,et al.  Influence of obesity on the metabolism of apolipoprotein B in humans. , 1985, The Journal of clinical investigation.